

HY-126876 · 50 mg
MedChemExpress · Cat: HY-126876
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/gl-v9.html
Description
GL-V9 inhibits proliferation of HepG2 cell IC50 is 35.2 ?M through induction of apoptosis and cell cycle arrest at G2/M phase. GL-V9 regulates mitochondrial membrane potential and increases the production of intracellular reactive oxygen species. GL-V9 inhibits the pentose phosphate pathway PPP , enhances fatty acid oxidation FAO through activation of AMPK, and thus inhibits the metastasis of cancer cells. GL-V9 exhibits antitumor efficacy in mouse model.







